Dr. Stefan Walzer

MAP - Market Access Podcast

Business EN ↓ 124 episodes

Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market...

Be sure to visit the podcast's website and support the creator: marketaccess-pricingstrategy.de

Author

Dr. Stefan Walzer

Category

Business

Latest episode

Nov 15, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

What Can Europe and the U.S. Learn from Each Other on Market Access, Anne Loos? 01.11.2025

Tune in to this new episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer is joined by Anne Loos from Wickenstones, to explore the evolving landscape of U.S. market access and reimbursement. The U.S. reimbursement landscape is changing — driven by AI, global influences with the European JCA and political programs such as the Inflation Reduction Act. As fragmentation and rising complex...

Will AI and Living Reviews Define the Next Era of Health Policy, Anna Forsythe? 15.10.2025

Join this episode of MAP – The Market Access Podcast as Dr. Stefan Walzer sits down with Anna Forsythe, founder of OncoScope-AI, to explore how Living Systematic Literature Reviews (Living SLRs) are redefining evidence generation in oncology and beyond - highlighting the power of real-time updates, advanced automation, and the essential role of human insight. Traditional SLRs are static snapshots,...

Are We Undervaluing the Economic Power of Health, Dr. Malina Müller? 01.10.2025

In the latest MAP Podcast, our host Dr. Stefan Walzer is joined by Dr. Malina Müller from the WifOR Institute to rethink how we value health. From real-world ROI data to policy shifts and long-term strategies, they explore why investing in health pays off—not just in lives saved, but in economic growth, workforce productivity, and resilient societies. Listen now to discover how viewing healthcare...

How Should Pharma Respond to the New Reality of Market Access in Germany, Prof. Dr. Thomas Hammerschmidt? 15.09.2025

In this episode of MAP - the Market Access Podcast, Dr. Stefan Walzer sits down with expert Prof. Dr. Thomas Hammerschmidt, to dive deep into Germany’s evolving AMNOG framework and what it really means for pharmaceutical pricing.  This insightful conversation explores key changes in Germany’s pharma landscape, including the shift from negotiation-based pricing to benefit-linked guardrails, th...

Do Swiss Reimbursement Reforms Open Doors—or Raise New Barriers, Petra Erni? 01.09.2025

Tune in to this episode of MAP – The Market Access Podcast, to hear from Dr. Stefan Walzer as he speaks with Swiss reimbursement expert Petra Erni, who brings a rare perspective from both the industry and payer sides. Together they explore the evolving Swiss drug reimbursement landscape, discussing the rise of cost consequence models, the growing role of health economic evidence, early access path...

The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff (Repost) 15.08.2025

This is a repost of a popular episode of MAP - Market Access Podcast, from December 1st 2023. We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO Dr. Stefan Walzer and the esteemed healthcare reimbursement expert, Ron de Graaff.  Ron, with his deep-rooted experience starting from 1978, shares his invaluable insights on the evolution of hea...

Europe vs. US: Who Leads the Future of Market Access, Dr. Doug Niven? 01.08.2025

In this thought-provoking episode of MAP, the Market Access Podcast, Dr. Stefan Walzer sits down with strategic Market Access consultant Dr. Doug Niven to explore one of the most pressing questions in pharma today - can Europe maintain its leadership in Market Access, or is it falling behind?  From joint HTA (JCA), pricing reforms, and AI-driven tools to global value frameworks and real-world...

What Does It Really Take to Master AMNOG in Today’s Market Access Landscape, Anja Pownell? 15.07.2025

Tune in to this new episode of the Market Access Podcast, where our host Dr. Stefan Walzer is joined by AMNOG expert Anja Pownell to bust some of the most persistent misconceptions about German market access—and share actionable survival tips for navigating the GBA process. Learn how to strategically prepare for AMNOG submissions, navigate price negotiations, and leverage AI tools to streamline do...

Is Cross-Functional Alignment the Secret to Successful Market Access, Kasem Akhras? 01.07.2025

In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with Kasem Akhras, veteran access strategist and author of Frontiers in Market Access , to unpack what it really takes to bring innovative therapies to patients across emerging markets. From the rising demand for innovative therapies to the tightening grip of healthcare budgets, this episode explores the real challenges and...

How Do You Unlock the Power of Statistics in Market Access, Necdet Gunsoy? 15.06.2025

Tune in to the latest episode of the Market Access Podcast, where Dr. Stefan Walzer welcomes statistician and Evimed founder Necdet Gunsoy to explore the critical role of statistics in health economics, HTA, and payer strategy. Learn how better collaboration between statisticians and market access teams can drive evidence-based decision-making, improve communication, and support strategic planning...

How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes? (Repost) 01.06.2025

This is a repost of a popular episode of MAP - Market Access Podcast, from July 15th 2024. Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this e...

How Can Market Access Professionals Plan for Long-Term Success, Adrian Kielhorn? 15.05.2025

What does it take to succeed in Market Access? In this brand new episode of MAP, the Market Access podcast, Dr. Stefan Walzer sits down with industry veteran Adrian Kielhorn, co-author of The Market Access Guide . Together, they unpack the evolving role of market access professionals, the power of strategic thinking, mastering negotiations, and why patient centricity is key to success. Learn how t...

What Are the Biggest Challenges & Opportunities of JCA, Dr. Nick Leach? 01.05.2025

In this brand new episode of MAP, the Market Access Podcast, our host Dr. Stefan Walzer is joined by Dr. Nick Leach, Market Access expert and managing director at Red Thread, to break down the Joint Clinical Assessment (JCA) process, its impact on pharma, biotech, and medical device companies, and how early advice can shape market access and reimbursement strategies in Europe. Tune in to learn abo...

Are We Overlooking the Real Benefits of Medical Innovation, Dr. Ahmed Seddik? 15.04.2025

Join the latest episode of the Market Access Podcast, where our host Dr. Stefan Walzer and expert Dr. Ahmed Seddik dissect the complexities of the societal impact of medical innovation. Dr. Ahmed Seddik shares important insights from his journey starting as a dentist in Egypt to his PhD research in health economics and social impact, focusing on how the access to innovation transforms communi...

What Are the Biggest Challenges in Implementing AI in Pharma, Jan Kroschinski? 01.04.2025

How can AI revolutionize Market Access, and what does it take to drive successful change in pharma? Tune into the latest episode of MAP, the Market Access Podcast, where our host Dr. Stefan Walzer and Jan Kroschinski, an expert in digital transformation, will delve into change management and AI adoption in pharma. Follow along as they explore how AI can streamline processes like dossier writing an...

How Can Startups Leverage Market Access to Attract Investors, Johan Olsson? 15.03.2025

In the latest episode of MAP, the Market Access Podcast, our host Dr. Stefan Walzer sits down with Johan Olsson, a seasoned life sciences investor, to uncover the critical role of market access and reimbursement in early-stage healthcare investments. They explore how early market access planning impacts healthcare startups, investment decisions, and commercialization success. Discover why pricing,...

How Are Data Privacy Laws Delaying Patient Access to New Treatments, Douglas Drake and Adam Skali? 01.03.2025

In this episode of MAP, Dr. Stefan Walzer, together with experts Douglas Drake and Adam Skali, unpacks the complexities of how GDPR regulations affect real-world evidence, cross-border studies, and market access in Europe. The discussion highlights data privacy challenges, delays in commercialization, and the future of healthcare data regulation. Learn more about how data privacy laws create barri...

How Can Innovation Planning Transform Market Access Success, Dr. Kasia Hein-Peters? 15.02.2025

Tune in to the latest episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer sits down with Amazon bestselling author Dr. Kasia Hein-Peters to explore the power of structured innovation planning. Get a deeper understanding of how healthcare companies better can balance short-term commercialization with long-term innovation, as well as what roles of AI, digital twins and scenario-based...

How does early Market Access bridge the gap between innovation and commercial success, Catherine Bacon? 01.02.2025

Discover the newest episode of MAP, the Market Access Podcast, your go-to podcast for all things Market Access. In todays episode our host Dr. Stefan Walzer dives deep into early market access in commercialization planning, bridging the gap between innovation and market success. Joined by Catherine Bacon, founder of Fingerpost Consulting, the conversation unpacks the critical steps early-stage hea...

A Flourishing Career in Pharmaceutical Market Access: Which Skills Are Essential, Dipti Tankala? (Repost) 15.01.2025

This is a repost of a popular episode of MAP - Market Access Podcast, from March 15th 2024. Explore the inspiring journey of Dipti Tankala in this podcast episode as she delves into market access within the pharmaceutical industry. From facing challenges in community pharmacy to leading in oncology market access, Dipti shares valuable insights on making impactful career transitions. Market Access...

What happens, when negotiations fail, Prof. Dr. Jürgen Wasem? (Repost) 15.12.2024

This is a repost of a popular episode of MAP - Market Access Podcast, from December 15th 2021. Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board. In this wide ranging conversation Dr. Stefan Walzer confronted Prof. Wasem...

How can people get equal access to pharmaceuticals, Dr. Nina Lathia? (Repost) 01.12.2024

This is a repost of a popular episode of MAP - Market Access Podcast, from April 15th 2023. All patients within all populations should have access to high quality medications that improve their health outcomes regardless of race, ethnicity, socio-economic status or any other individual factors,  wrote Dr. Utibe R. Essien in an  Jama article 2021 . But how does reality look like...

How might digitization change health care in Germany by 2035, Julian Molitor? (Repost) 15.11.2024

This is a repost of a popular episode of MAP - Market Access Podcast, from October 1st 2022. Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next years. Germany has started by implementing digital health applications (“DIGAs”) and is currently on its way to improve the digital infrastructure in hospitals. Anyway, some core questions...

How to optimize commercialisation of innovative life science products, Dr. Kasia Hein-Peters? (Repost) 01.11.2024

This is a repost of a popular episode of MAP, Market Access Podcast, from 15th of July 2023. Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important how could this situation be improved? In this podcast episode, Dr. Stefan Walzer and...

What does environmental sustainability mean for Market Access, Gerdi Strydom? 15.10.2024

Join us on the latest episode of MAP - the Market Access Podcast - where our host Dr. Stefan Walzer, together with special guest Gerdi Strydom, Managing Director at Valid Insight, explore the integration of ESG (Environmental, Social, and Governance) into Health Technology Assessments (HTAs). In this episode, they unpack how healthcare's carbon footprint and environmental impact are influencing po...

Listen to the MAP - Market Access Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.